Sylvie NEGRIER, PhD
Centre Leon Berard · Centre Léon Bérard; Lyon; FRANCE
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Sylvie NEGRIER, PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:53 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT05096390 · Axitinib +/- Pembrolizumab in First Line Treatment of mPRCCCentre Leon Berard · unknown · Papillary Renal Cell Carcinoma Type 2 · principal investigator
- Ph3NCT03408652 · Efficacy and Safety of Systemic Treatments of Bone Metastases From Kidney Cancer in Patients Treated With Targeted TherapiesCentre Leon Berard · terminated · Metastatic Renal Cell Carcinoma · principal investigator
- Ph2NCT02489695 · Axitinib in1st Line Treatment for Patients With Advanced or Metastatic Papillary Renal Cell CarcinomaCentre Leon Berard · completed · Papillary Renal Cell Carcinoma · principal investigator
- Ph1NCT01202032 · Multicenter Dose-escalation Study of a Combination of Pazopanib and Bevacizumab in Patients With Metastatic Renal Cell Carcinoma or Others Advanced Solid TumorsCentre Leon Berard · completed · Metastatic Renal Cell Carcinoma, Advanced Refractory Solid Tumors Histologically or Cytologically Confirmed · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:53 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.